Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 229

    1.

    Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study.

    Sacu S, Varga A, Michels S, Weigert G, Polak K, Vécsei-Marlovits PV, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Oct;92(10):1347-51. Epub 2008 Jun 27.PMID: 18586901 [PubMed - indexed for MEDLINE]Related articles

    2.

    [Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration]

    Hahn R, Sacu S, Michels S, Varga A, Weigert G, Geitzenauer W, Vécsei-Marlovits P, Schmidt-Erfurth U.

    Ophthalmologe. 2007 Jul;104(7):588-93. German. PMID: 17564719 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

    4.

    Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

    Chaudhary V, Mao A, Hooper PL, Sheidow TG.

    Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles

    5.

    Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy.

    Piermarocchi S, Sartore M, Lo Giudice G, Maritan V, Midena E, Segato T.

    Arch Ophthalmol. 2008 Oct;126(10):1367-74.PMID: 18852414 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.

    Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E, Weinberger D.

    Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec;37(6):455-61.PMID: 17152538 [PubMed - indexed for MEDLINE]Related articles

    8.

    Changes in macular sensitivity after reduced fluence photodynamic therapy combined with intravitreal triamcinolone.

    Dunavoelgyi R, Sacu S, Simader C, Pruente C, Schmidt-Erfurth U.

    Acta Ophthalmol. 2009 Oct 27. [Epub ahead of print]PMID: 19860783 [PubMed - as supplied by publisher]Related articles

    9.

    Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.

    Iwama D, Otani A, Sasahara M, Yodoi Y, Gotoh N, Tamura H, Tsujikawa A, Yoshimura N.

    Br J Ophthalmol. 2008 Oct;92(10):1352-6. Epub 2008 Jul 28.PMID: 18662914 [PubMed - indexed for MEDLINE]Related articles

    10.

    Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.

    Schadlu R, Kymes SM, Apte RS.

    Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1667-72. Epub 2007 Jun 22.PMID: 17583819 [PubMed - indexed for MEDLINE]Related articles

    11.

    Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.

    Krebs I, Krepler K, Stolba U, Goll A, Binder S.

    Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):237-43. Epub 2007 Aug 3.PMID: 17674018 [PubMed - indexed for MEDLINE]Related articles

    12.

    A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.

    Krebs I, Binder S, Stolba U.

    Graefes Arch Clin Exp Ophthalmol. 2006 Jul;244(7):863-7. Epub 2005 Dec 6.PMID: 16331486 [PubMed - indexed for MEDLINE]Related articles

    13.

    Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):245-54. Epub 2007 Aug 3.PMID: 17674020 [PubMed - indexed for MEDLINE]Related articles

    14.

    The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration.

    Roth DB, Kulkarni KM, Feuer WJ.

    Ophthalmic Surg Lasers Imaging. 2008 Jan-Feb;39(1):12-6.PMID: 18254345 [PubMed - indexed for MEDLINE]Related articles

    15.

    Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization.

    Hussain N, Das T, Rawal H, Kallukuri SB, Mohan Ram LS, Khanna R.

    Indian J Ophthalmol. 2006 Dec;54(4):247-50.PMID: 17090876 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.

    Iriyama A, Obata R, Inoue Y, Takahashi H, Tamaki Y, Yanagi Y.

    Graefes Arch Clin Exp Ophthalmol. 2008 Mar;246(3):339-44. Epub 2007 Sep 6.PMID: 17805556 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.

    Lee J, Freeman WR, Azen SP, Chung EJ, Koh HJ.

    Retina. 2007 Nov-Dec;27(9):1205-13.PMID: 18046226 [PubMed - indexed for MEDLINE]Related articles

    18.

    Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion.

    Chung EJ, Lee H, Koh HJ.

    Graefes Arch Clin Exp Ophthalmol. 2008 Jul;246(7):967-74. Epub 2008 Apr 19.PMID: 18425522 [PubMed - indexed for MEDLINE]Related articles

    19.

    Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.

    Ruiz-Moreno JM, Montero JA, Zarbin MA.

    Retina. 2007 Apr-May;27(4):458-61.PMID: 17420698 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data